KAT6B and neuroblastoma: We identified several gained super-enhancers associated with genes involved in retinol uptake, and neuronal differentiation related to early development, such as RBP1 and KAT6B, suggesting that ATRA treatment may induce neuroblastoma differentiation by promoting the activation of key super-enhancer networks associated with cell differentiation and development.